Abstract:<h3 class="a-plus-plus">Abstract</h3> <span class="a-plus-plus abstract-section id-a-sec1"> <h3 class="a-plus-plus">Background</h3> <p class="a-plus-plus">Human carbonyl reductase 1 (CBR1) plays major roles in protecting cells against cellular damage resulting from oxidative stress. Although CBR1-mediated detoxification of oxidative materials increased by stressful conditions including hypoxia, neuronal degenerative disorders, and other circumstances generating reactive oxide is well documented, the role of CBR1 under ionising radiation (IR) is still unclear.</p> </span> <span class="a-plus-plus abstract-section id-a-sec2"> <h3 class="a-plus-plus">Methods</h3> <p class="a-plus-plus">The formalin-fixed and paraffin-embedded tissues of 85 patients with head and neck squamous cell carcinoma (HNSCC) were used to determine if CBR1 expression effects on survival of patients with treatment of radiotherapy. Subsequently colony formation assays and xenograft tumor mouse model was used to verify the relationship between CBR1 expression and radiosensitivity in HNSCC cells. Publicly-available data from The Cancer Genome Atlas (TCGA) was analysed to determine if CBR1 expression affects the survival of patients with HNSCC. To verify CBR1-mediated molecular signalling pathways, cell survival, DNA damage/repair, reactive oxygen species (ROS), cell cycle distribution and mitotic catastrophe in HNSCC cells with modulated CBR1 expression by knockdown or overexpression were measured using by colony formation assays, flow cytometry, qRT-PCR and western blot analysis.</p> </span> <span class="a-plus-plus abstract-section id-a-sec3"> <h3 class="a-plus-plus">Results</h3> <p class="a-plus-plus">HNSCC patients with low CBR1 had a significantly higher survival rate than the high CBR1 expression (84.2% vs. 57.8%, <em class="a-plus-plus">p</em> = 0.0167). Furthermore, HNSCC patients with low CBR1 expression showed a good prognosis for IR compared to patients with highly expressed CBR1. Also, we found that IR upregulated CBR1 mRNA via Nrf2 activation in HNSCC cells and patients. In vitro analysis, we found that CBR1-specific siRNA or inhibitor significantly enhanced radiosensitivity after IR, while CBR1 overexpression decreased. CBR1 inhibition by siRNA or inhibitor treatment accumulated cellular ROS leading to aberrant DNA damage repair and an increase of mitotic catastrophe. Moreover, the combination of CBR1 depletion with IR dramatically inhibited primary tumour growth in a xenograft tumor mouse model.</p> </span> <span class="a-plus-plus abstract-section id-a-sec4"> <h3 class="a-plus-plus">Conclusion</h3> <p class="a-plus-plus">Our findings indicate that CBR1 has a key role in DNA damage response through regulation of IR-mediated ROS generation. Consistently, CBR1 expression is highly correlated with patient survival after and susceptibility to radiation therapy. Therefore, CBR1 inhibition with IR might be a potent therapeutic strategy for HNSCC treatment.</p> </span>

Effect of YC-1 on Improving Hypoxia and Radiosensitizing Human Lung Adenocarcinoma Cellsin Vitro

Effects of YC-1 on Hypoxia-Inducible Factor 1 Alpha in Hypoxic Human Bladder Transitional Carcinoma Cell Line T24 Cells.

Radiosensitizing effects of cyclooxygenase-2 selective inhibitor LM-1685 on A549 human lung adenocarcinoma cells

Effect of 5-Azn-2'-deoxycytidine on Proliferation of Human Lung Adenocarcinoma Cell Line A549 in Vitro

Radiosensitive Effect of Hypoxia-inducible factor 1α Inhibitor YC-1 on Hypoxic Glioma SHG44 Cell Line

Anticancer Mechanisms of YC-1 in Human Lung Cancer Cell Line, NCI-H226.

Effects of YC-1 Targeting Hypoxia-Inducible Factor 1 Alpha in Oesophageal Squamous Carcinoma Cell Line Eca109 Cells.

[The Effect of Ixabepilone on NSCLC Cells Radio-Sensitivity under Quiescent or Hypoxic Condition].

Effect of HIF-1αby RNAi on Radiosensitivity in Esophageal Squamous Carcinoma Cell Line Eca109 under Hypoxia

YC-1 sensitizes the antitumor effects of boron neutron capture therapy in hypoxic tumor cells

Synthesis And Biological Evaluation Of 3-Aryl-Quinoxaline-2-Carbonitrile 1,4-Di-N-Oxide Derivatives As Hypoxic Selective Anti-Tumor Agents

Proteomic Approach to Studying the Cytotoxicity of YC‐1 on U937 Leukemia Cells and Antileukemia Activity in Orthotopic Model of Leukemia Mice

Gefitinib at different administration time in radiosensitizing lung adenocarcinoma cells in vitro

The killing effect of rmhTNF-α combined with gemcitabine on human lune adenocarcinoma cells A549

P-Y/G@NHs sensitizes non-small cell lung cancer cells to radiotherapy via blockage of the PI3K/AKT signaling pathway

2-(3-Fluorophenyl)-6-methoxyl-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid (YJC-1) Induces Mitotic Phase Arrest in A549 Cells

Effects of Carbon-Ion Beam Irradiation on the Angiogenic Response in Lung Adenocarcinoma A549 Cells.

Study on the sensitizing effect of SM-1 combined with irradiation on head and neck squamous cell carcinoma

Influence of Radiosensitivity by Mild Hyperthermia in a Pulmonary Adenocarcinoma Cell Line

Enhancement of radiosensitivity by roscovitine pretreatment in human non-small cell lung cancer A549 cells.

Carbonyl reductase 1 is a new target to improve the effect of radiotherapy on head and neck squamous cell carcinoma